# COMT Polymorphism and Entacapone Efficacy

> **NCT00373087** · PHASE4 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 60 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** entacapone
- **DRUG:** l dopa versus placebo

## Key facts

- **NCT ID:** NCT00373087
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2010-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00373087

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00373087, "COMT Polymorphism and Entacapone Efficacy". Retrieved via MORVS 2026-11-02 from https://api.morvs.ai/clinical/NCT00373087. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*